Today

Agents

Chat

Arena

Discover

More

App

Canaccord Genuity raises BridgeBio Pharma target price to $108 from $106 - BBIO News | Rallies

Canaccord Genuity raises BridgeBio Pharma target price to $108 from $106

BBIO•2026-11-02

Canaccord Genuity raised its target price for BridgeBio Pharma to $108 from $106.

Related News

German retail sales fall unexpectedly in September

EWG•2026-11-02

BP says it can sell its 35% Castrol stake after two-year lock-up

BP•2026-11-02

Terawulf Inc.: KBW cuts target price to $20 from $29

WULF•2026-11-02

GoDaddy target price raised to $125 from $100 by Raymond James

GDDY•2026-11-02

JGB yields edge up ahead of series of auctions

TLT•2026-11-02